Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Open-market buys, last 90 days
$40,000
in 1 filing
Open-market sales, last 90 days
$421,679
in 7 filings, $422K under 10b5-1 plans

Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Lucera Erick Chief Financial Officer Sale 10b5-1 −1,991 $16.82 $33K 117,775
2026-08-13 Lucera Erick Chief Financial Officer Sale 10b5-1 −1,797 $26.28 $47K 119,766
2026-06-25 Lucera Erick Chief Financial Officer Sale −2,362 $20.37 $48K 121,563
2026-05-13 Lucera Erick Chief Financial Officer Sale 10b5-1 −1,448 $18.36 $27K 123,925
2026-04-01 Lucera Erick Chief Financial Officer Sale 10b5-1 −5,727 $18.64 $107K 125,373
2026-02-12 Lucera Erick Chief Financial Officer Grant or award +65,000 131,100
2026-02-12 Lucera Erick Chief Financial Officer Grant or award · Stock Option (Right to Buy) +105,000 105,000
2025-03-31 Lucera Erick Chief Financial Officer Grant or award +66,100 66,100
2025-03-31 Lucera Erick Chief Financial Officer Grant or award · Stock Option (Right to Buy) +214,500 214,500

Page 1 of 1 · 9 trades